Absence of gut microbiota during early life affects anxiolytic Behaviors and monoamine neurotransmitters system in the hippocampal of mice

J Neurol Sci. 2019 May 15:400:160-168. doi: 10.1016/j.jns.2019.03.027. Epub 2019 Mar 29.

Abstract

The gut microbiome is composed of an enormous number of microorganisms, generally regarded as commensal bacteria. Resident gut bacteria are an important contributor to health and significant evidence suggests that the presence of healthy and diverse gut microbiota is important for normal cognitive and emotional processing. Here we measured the expression of monoamine neurotransmitter-related genes in the hippocampus of germ-free (GF) mice and specific-pathogen-free (SPF) mice to explore the effect of gut microbiota on hippocampal monoamine functioning. In total, 19 differential expressed genes (Htr7, Htr1f, Htr3b, Drd3, Ddc, Maob, Tdo2, Fos, Creb1, Akt1, Gsk3a, Pik3ca, Pla2g5, Cyp2d22, Grk6, Ephb1, Slc18a1, Nr4a1, Gdnf) that could discriminate between the two groups were identified. Interestingly, GF mice displayed anxiolytic-like behavior compared to SPF mice, which were not reversed by colonization with gut microbiota from SPF mice. Besides, colonization of adolescent GF mice by gut microbiota was not sufficient to reverse the altered gene expression associated with their GF status. Taking these findings together, the absence of commensal microbiota during early life markedly affects hippocampal monoamine gene-regulation, which was associated with anxiolytic behaviors and monoamine neurological signs.

Keywords: Anxiety-like behavior; Colonization; Gut microbiota; Microbiota-gut-brain axis; Monoamine neurotransmitters.

MeSH terms

  • Animals
  • Anxiety / etiology
  • Anxiety / genetics*
  • Anxiety / psychology
  • Biogenic Monoamines / metabolism
  • Gastrointestinal Microbiome / physiology*
  • Gene Regulatory Networks / physiology
  • Germ-Free Life / physiology*
  • Hippocampus / metabolism*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neurotransmitter Agents / genetics*
  • Neurotransmitter Agents / metabolism*
  • Random Allocation

Substances

  • Biogenic Monoamines
  • Neurotransmitter Agents